2025-522630-31-00招募中1 期
Evaluation of AG-181 in Subjects 18 to 69 Years of Age With Phenylketonuria
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 10
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Scientific Communications
Scientific
Agios Pharmaceuticals Inc.
研究点 (2)
Loading locations...
相似试验
已完成
1 期
A study in healthy men to test whether BI 1815368 influences the amount of metformin in the body2024-515911-23-00Boehringer Ingelheim International GmbH14
已完成
1 期
A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-068214972023-508371-36-00Pfizer Inc.6
已完成
1 期
An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)NCT07361354Angitia Incorporated Limited28
暂停
1 期
A study in healthy men to test how BI 1839100 is taken up and handled by the body2024-510870-26-00Boehringer Ingelheim International GmbH16
招募中
1 期
Study in healthy male participants to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as multiple intravenous injections as well as safety, tolerability and the effects on certain blood values.Treatment of symptomatic anemia associated with chronic renal failure:2025-522246-43-00Blau Farmaceutica S.A.124